IRVINE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated pericardial transcatheter aortic valve replacement (TAVR) systems for...
JenaValve Raises $62.5 Million In Venture Funding Capital to Fund Clinical Study for Transfemoral TAVI system, Expansion of Commercial Initiatives PR Newswire WILMINGTON, Del. and MUNICH, July...
Seed developer sells subordinated notes that will convert to stock in its IPO --Purchasers will receive a 20% discount from the IPO price --Artal Luxembourg SA purchased the largest portion of the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.4 | 3.62694300518 | 38.6 | 41.6 | 38.1 | 29898 | 40.24475858 | DE |
4 | 1.85 | 4.84927916121 | 38.15 | 41.6 | 36.6 | 19863 | 38.66495478 | DE |
12 | -1.05 | -2.55785627284 | 41.05 | 43.4 | 36.6 | 16889 | 40.13394968 | DE |
26 | -6.85 | -14.62113127 | 46.85 | 47.05 | 36.6 | 15701 | 41.24395192 | DE |
52 | -3.2 | -7.40740740741 | 43.2 | 47.1 | 36.6 | 16199 | 42.80831614 | DE |
156 | -13.3 | -24.9530956848 | 53.3 | 56.3 | 36.15 | 15008 | 45.05241783 | DE |
260 | -15.5 | -27.9279279279 | 55.5 | 59.4 | 36.15 | 14866 | 47.40353981 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.